相关实验视频
Updated: Jun 14, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.0K
炎症性肠病中的肠外表现:从病理生理学到治疗
Ilaria Faggiani1,2, Jacopo Fanizza1,2, Ferdinando D'Amico1
1Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, 20132 Milan, Italy.
Biomedicines
|August 29, 2024
概括
炎症性肠道疾病 (IBD) 影响整个身体,导致肠道以外的各种症状. 了解和治疗这些肠外表现对于改善患者的生活质量至关重要.
科学领域:
- 胃肠道学和免疫学
- 系统性炎症性疾病系统性炎症性疾病
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病和性结肠炎,是系统性疾病,具有显著的肠外表现 (EIM).
- EIMs影响患者的生活质量,并且可以在一生中影响高达50%的IBD患者.
- 一些EIM与活跃的肠道炎症相关,而另一些则独立发生,某些IBD疗法也可以引起类似的症状.
研究的目的:
- 提供IBD中EIM病理生理学的全面审查.
- 分析与克罗恩病和性结肠炎相关的EIM目前的治疗策略.
- 区分与疾病活动相关的EIM与独立于爆发或治疗副作用的EIM.
主要方法:
- 文献综述和对IBD和EIM现有研究的综合.
- 分析了各种EIM背后的机制.
- 基于其与肠道炎症和治疗干预措施的关联,对EIMs的治疗方法的评估.
主要成果:
- 周围关节炎,表皮质炎和结节性红斑通常与活跃的肠道炎症有关,并且对IBD治疗有反应.
- 前性紫外炎,性脊柱炎和原发性硬化性胆管炎通常独立于肠道疾病爆发而表现.
- 先进的IBD疗法可能会出现模仿EIM的副作用,需要仔细的差异诊断.
结论:
- 电子投资项目是IBD的一个重要而复杂的组成部分,需要定制的管理策略.
- 区分EIM的原因 (疾病活动,独立过程或治疗副作用) 对于有效的患者护理至关重要.
- 需要进一步研究IBD相关EIM的病理生理学和向治疗方法.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
01:17Chronic Bowel Disorders: Introduction
414
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
414
01:29Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145